CRISPR-related stocks sink after report that gene-editing technology might cause cancer
June 11, 2018 at 16:59 PM EDT
Shares of gene-therapy companies sank in active trade Monday, after a STAT report that editing a cell’s genome with CRISPR/Cas9 technology might cause cancer.
